Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Asthma: LABAs should not be used alone

The U.S. Food and Drug Administration today announced that drugs in the class of long-acting beta agonists (LABAs) should never be used alone in the treatment of asthma in children or adults. Manufacturers will be required to include this warning in the product labels of these drugs, along with taking other steps to reduce the overall use of these medications.

19 Feb 2010

Pipe and cigar smoking linked to decreased lung function

Pipe and cigar smoke may be more harmful than once thought. While some believe pipes and cigars are healthier than cigarettes, a major known cause of chronic obstructive pulmonary disease (COPD), a new study directly links pipe and cigar smoking to decreased lung function.

16 Feb 2010

Report shows 3.4% of adult Minnesotans suffer from COPD

The nation's fourth leading cause of death, chronic obstructive pulmonary disease (COPD), is now being measured by the Minnesota Department of Health's Environmental Public Health Tracking Program. The program focuses on three major causes of hospitalizations in Minnesota that can be triggered or made worse by environmental factors such as secondhand smoke or outdoor air pollution — asthma, heart attacks and COPD.

10 Feb 2010

Bioethicists create easy-to-remember checklist to assess patient's decision-making capacity in emergency

Physicians in training and bioethicists at Johns Hopkins have created an easy-to-remember checklist to help medical students and clinicians quickly assess a patient's decision-making capacity in an emergency.

5 Feb 2010

CCHP implements TriZetto systems to improve its network and health management programs

The TriZetto Group, Inc. today announced that Chinese Community Health Plan (CCHP) has successfully implemented several TriZetto systems, including the Facets®, NetworX Pricer® and Clinical CareAdvance® applications.

5 Feb 2010

February issue of Chest releases latest medical news

Inhaled corticosteroids (ICS) are widely used for the treatment of chronic obstructive pulmonary disease (COPD). However, new research suggests that ICS may only provide a modest benefit in reducing exacerbations in patients with COPD.

4 Feb 2010

Innovative discharge program reduces congestive heart failure readmissions

An innovative discharge program developed by Saddleback Memorial Medical Center combining coordination of hospital and community resources, strong patient education and the IDEAL LIFE Bluetooth-enabled wireless remote health monitoring system has helped to reduce congestive heart failure (CHF) readmissions by 50 percent

3 Feb 2010

CTS: More people are being admitted to Canadian hospitals each year with COPD

A review of Canadian data by the nation's leading lung specialists has provided the factual evidence to support what respirologists across the country have been suspecting for some time. Shockingly, more people are being admitted to Canadian hospitals each year with chronic obstructive pulmonary disease (COPD) than any other major chronic illness (including heart attacks) and that number has been increasing dramatically in recent years.

2 Feb 2010

Study shows benefits of endoscopic sinus surgery for patients with chronic sinusitis

Adults with chronic rhinosinusitis -a debilitating inflammation of the nasal passages that lasts for months and keeps coming back - report significantly improved quality of life following minimally invasive endoscopic sinus surgery, according to a new study led by Oregon Health & Science University (OHSU).

28 Jan 2010

Patients with COPD could benefit from treatment with drugs that block sestrin function

Chronic obstructive pulmonary disease (COPD) is defined by emphysema and/or chronic bronchitis. It destroys the normal architecture of the lung and inhibits the mechanical aspects of breathing, which prevents necessary gas exchange. Patients suffer from coughing fits, wheezing, and increased incidence of lung infections.

27 Jan 2010

Elevation Pharmaceuticals closes $30M tranched Series A financing

Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today the closing of a $30 million tranched Series A financing.

21 Jan 2010

Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations

Chronic obstructive pulmonary disease (COPD) affects a large number of subjects worldwide and is characterised by a progressively rising epidemiological, clinical and socio-economic impact. The objectives of treatment are to decrease the burden of the disease through relief of symptoms, improvement of exercise tolerance, and prevention and treatment of exacerbations.

21 Jan 2010

Research shows strong links between COPD and heart function

A common lung condition, COPD (chronic obstructive pulmonary disease) diminishes the heart's ability to pump effectively even when the disease has no or mild symptoms, according to research published in the Jan. 21 issue of the New England Journal of Medicine.

21 Jan 2010

One-legged cycling can improve overall fitness in COPD patients

People with chronic-obstructive pulmonary disease (COPD) often find themselves in a downward spiral when it comes to their health. COPD, which includes chronic bronchitis and emphysema, means that the elasticity of the lungs is destroyed.

21 Jan 2010

Study: Heart's ability to pump effectively is diminished among people with common lung disease

A new study from Columbia University Medical Center researchers, has found that the heart's ability to pump effectively is diminished among people with a common lung disease, even in people with no or mild symptoms.

21 Jan 2010

FDA: Data from Spiriva HandiHaler do not support increased risks for stroke, heart attack or death

The U.S. Food and Drug Administration today announced that data from a recent review of the Spiriva HandiHaler, a long-acting respiratory treatment for chronic obstructive pulmonary disease (COPD), do not support an increased risk of stroke, heart attack, or death in patients using the medicine.

18 Jan 2010

Researchers identify ways to predict patients with small-cell lung cancer

Researchers for TGen Clinical Research Services at Scottsdale Healthcare (TCRS) have identified a way to predict which patients with small-cell lung cancer may be resistant to first-line chemotherapy.

18 Jan 2010

Three tumor microRNAs may help identify chemoresistance in small cell lung cancer patients

At least three tumor microRNAs appear to predict when first-line chemotherapy will prove ineffective in some patients with small cell lung cancer, according to data presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer, held Jan. 11-14, 2010.

13 Jan 2010

'Make Today the Day' public awareness campaign to quit smoking launched

At a time when many smokers consider quitting for the New Year, today is a timely launch of a partnership that joins together mutual public health interests sought by the American Lung Association in California, Healthy San Francisco and the city's Public Health Office in a citywide public awareness campaign aimed to help smokers achieve that goal.

6 Jan 2010

GE Healthcare and Intel expand sales and marketing agreement for Intel Health Guide in the U.K.

GE Healthcare, a unit of GE, and Intel Corporation (NASDAQ:INTC) announced today that they have expanded their sales and marketing agreement for the Intel Health Guide to include the United Kingdom. GE Healthcare already markets the Intel Health Guide in the United States.

5 Jan 2010

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Asthma: LABAs should not be used alone

Pipe and cigar smoking linked to decreased lung function

Report shows 3.4% of adult Minnesotans suffer from COPD

Bioethicists create easy-to-remember checklist to assess patient's decision-making capacity in emergency

CCHP implements TriZetto systems to improve its network and health management programs

February issue of Chest releases latest medical news

Innovative discharge program reduces congestive heart failure readmissions

CTS: More people are being admitted to Canadian hospitals each year with COPD

Study shows benefits of endoscopic sinus surgery for patients with chronic sinusitis

Patients with COPD could benefit from treatment with drugs that block sestrin function

Elevation Pharmaceuticals closes $30M tranched Series A financing

Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations

Research shows strong links between COPD and heart function

One-legged cycling can improve overall fitness in COPD patients

Study: Heart's ability to pump effectively is diminished among people with common lung disease

FDA: Data from Spiriva HandiHaler do not support increased risks for stroke, heart attack or death

Researchers identify ways to predict patients with small-cell lung cancer

Three tumor microRNAs may help identify chemoresistance in small cell lung cancer patients

'Make Today the Day' public awareness campaign to quit smoking launched

GE Healthcare and Intel expand sales and marketing agreement for Intel Health Guide in the U.K.

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in